These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 28050892)
1. In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma. Ray S; Saha S; Sa B; Chakraborty J Drug Deliv Transl Res; 2017 Apr; 7(2):259-275. PubMed ID: 28050892 [TBL] [Abstract][Full Text] [Related]
2. Melatonin releasing PLGA micro/nanoparticles and their effect on osteosarcoma cells. Altındal DÇ; Gümüşderelioğlu M J Microencapsul; 2016 Feb; 33(1):53-63. PubMed ID: 26605784 [TBL] [Abstract][Full Text] [Related]
3. In vivo anticancer activity of methotrexate-loaded layered double hydroxide nanoparticles. Choi SJ; Oh JM; Chung HE; Hong SH; Kim IH; Choy JH Curr Pharm Des; 2013; 19(41):7196-202. PubMed ID: 23489199 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma. Fujita Y; Nakamura T; Aomori T; Nishiba H; Shinozaki H; Yanagawa T; Takagishi K; Watanabe H; Okada Y; Nakamura K; Horiuchi R; Yamamoto K J Chemother; 2010 Jun; 22(3):186-90. PubMed ID: 20566424 [TBL] [Abstract][Full Text] [Related]
5. Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma. Hegyi M; Gulácsi A; Cságoly E; Csordás K; Eipel OT; Erdélyi DJ; Müller J; Nemes K; Lautner-Csorba O; Kovács GT J Cancer Res Clin Oncol; 2012 Oct; 138(10):1697-702. PubMed ID: 22652833 [TBL] [Abstract][Full Text] [Related]
6. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863 [TBL] [Abstract][Full Text] [Related]
7. Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model. Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM Anticancer Res; 2022 Feb; 42(2):731-737. PubMed ID: 35093871 [TBL] [Abstract][Full Text] [Related]
8. A novel platform designed by Au core/inorganic shell structure conjugated onto MTX/LDH for chemo-photothermal therapy. Tian DY; Wang WY; Li SP; Li XD; Sha ZL Int J Pharm; 2016 May; 505(1-2):96-106. PubMed ID: 26997424 [TBL] [Abstract][Full Text] [Related]
9. Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma. Liu P; Sun L; Zhou DS; Zhang P; Wang YH; Li D; Li QH; Feng RJ Sci Rep; 2015 Dec; 5():17387. PubMed ID: 26619950 [TBL] [Abstract][Full Text] [Related]
10. Improved design and characterization of PLGA/PLA-coated Chitosan based micro-implants for controlled release of hydrophilic drugs. Manna S; Donnell AM; Kaval N; Al-Rjoub MF; Augsburger JJ; Banerjee RK Int J Pharm; 2018 Aug; 547(1-2):122-132. PubMed ID: 29857096 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation. Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663 [TBL] [Abstract][Full Text] [Related]
12. Mg-Al layered double hydroxide-methotrexate nanohybrid drug delivery system: evaluation of efficacy. Chakraborty J; Roychowdhury S; Sengupta S; Ghosh S Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):2168-74. PubMed ID: 23498245 [TBL] [Abstract][Full Text] [Related]
13. Anionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer model. Choi G; Piao H; Alothman ZA; Vinu A; Yun CO; Choy JH Int J Nanomedicine; 2016; 11():337-48. PubMed ID: 26855572 [TBL] [Abstract][Full Text] [Related]
14. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment. Rong ZJ; Yang LJ; Cai BT; Zhu LX; Cao YL; Wu GF; Zhang ZJ J Mater Sci Mater Med; 2016 May; 27(5):89. PubMed ID: 26975746 [TBL] [Abstract][Full Text] [Related]
15. Intracellular drug delivery of layered double hydroxide nanoparticles. Oh JM; Park CB; Choy JH J Nanosci Nanotechnol; 2011 Feb; 11(2):1632-5. PubMed ID: 21456254 [TBL] [Abstract][Full Text] [Related]
16. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications. Tahir N; Madni A; Balasubramanian V; Rehman M; Correia A; Kashif PM; Mäkilä E; Salonen J; Santos HA Int J Pharm; 2017 Nov; 533(1):156-168. PubMed ID: 28963013 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma. Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931 [TBL] [Abstract][Full Text] [Related]
18. Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination. Bain E; Birhiray RE; Reeves DJ Ann Pharmacother; 2014 Feb; 48(2):292-6. PubMed ID: 24259648 [TBL] [Abstract][Full Text] [Related]
19. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study. Choi SJ; Oh JM; Choy JH J Nanosci Nanotechnol; 2010 Apr; 10(4):2913-6. PubMed ID: 20355523 [TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of methotrexate loaded poly(lactic-co-glycolic) acid microspheres and antitumor efficacy in Sarcoma-180 mice bearing tumor. Singh UV; Udupa N Pharm Acta Helv; 1997 Jun; 72(3):165-73. PubMed ID: 9204775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]